Elevated levels of IgM and IgA antibodies to Proteus mirabilis and IgM antibodies to Escherichia coli are associated with early rheumatoid factor (RF)-positive rheumatoid arthritis

Rheumatology

Volumn 44, Issue 11, 2005, Pages 1433-1441

  Newkirk, Marianna M ^f   Goldbach Mansky, R ^a   Senior, B W ^b   Klippel, J ^c   Schumacher Jr , H R ^d   El Gabalawy, H S ^e  

^a NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES   (United States)

^b UNIVERSITY OF DUNDEE   (United Kingdom)

^c ARTHRITIS FOUNDATION   (United States)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

^e UNIVERSITY OF MANITOBA   (Canada)

^f MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

Author keywords

Early synovitis; Proteus antibodies; Rheumatoid arthritis; Rheumatoid factor; Spondylarthritis

Indexed keywords

ADVANCED GLYCATION END PRODUCT; DISEASE MODIFYING ANTIRHEUMATIC DRUG; EPITOPE; HLA ANTIBODY; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; NONSTEROID ANTIINFLAMMATORY AGENT; PREDNISOLONE; RHEUMATOID FACTOR;

ADULT; ANALYSIS OF VARIANCE; ANTIBODY DETECTION; ANTIBODY TITER; ARTICLE; CAMPYLOBACTER; CHLAMYDIA; CLINICAL TRIAL; DISEASE ASSOCIATION; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; ESCHERICHIA COLI; FEMALE; FOLLOW UP; FOOT RADIOGRAPHY; HAND RADIOGRAPHY; HUMAN; MAJOR CLINICAL STUDY; MALE; PARVOVIRUS; PATHOGENESIS; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEUS MIRABILIS; RHEUMATOID ARTHRITIS; SALMONELLA; SHIGELLA; SPONDYLOARTHROPATHY; SYNOVITIS; YERSINIA;

ADULT; ANTIBODIES, ANTI-IDIOTYPIC; ANTIBODIES, BACTERIAL; ARTHRITIS, RHEUMATOID; BIOLOGICAL MARKERS; ESCHERICHIA COLI; FEMALE; HUMANS; IMMUNOGLOBULIN A; IMMUNOGLOBULIN M; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PROTEUS MIRABILIS; RHEUMATOID FACTOR; SPONDYLARTHRITIS; SYNOVITIS;

EID: 27544474915     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/kei036     Document Type: Article

References (41)

1. Fox D. Etiology and pathogenesis of rheumatoid arthritis. In: Koopman WJ, ed. Arthritis and allied conditions. 14th edn. Philadelphia: Lippincott, Williams & Wilkins, 2001:1085-102.
2. Gabriel SE, Crowson CS, O'Fallon WM. Mortality in rheumatoid arthritis: have we made an impact in 4 decades? J Rheumatol 1999; 26:2529-33.
3. Young A, Dixey J, Kulinskaya E et al. Which patients stop working because of rheumatoid arthritis? Results of five years' follow up in 732 patients from the Early RA Study (ERAS). Ann Rheum Dis 2002; 61:335-40.
4. El Gabalawy HS, Duray P, Goldbach-Mansky R. Evaluating patients with arthritis of recent onset: Studies in pathogenesis and prognosis. JAMA 2000;284:2368-73.
5. Albani S, Keystone EC, Nelson JL et al. Positive selection in autoimmunity: Abnormal immune responses to a bacterial dnaJ antigenic determinant in patients with early rheumatoid. Nat Med 1995;1:448-52.
6. Rashid T, Darlington G, Kjeldsen-Kragh J, Forre O, Collado A, Ebringer A. Proteus IgG antibodies and C-reactive protein in English, Norwegian and Spanish patients with rheumatoid arthritis. Clin Rheumatol 1999;18:190-5.
7. Senior BW, McBride PD, Morley KD, Kerr MA. The detection of raised levels of IgM to Proteus mirabilis in sera from patients with rheumatoid arthritis. J Med Microbiol 1995;43:176-84.
8. Blankenberg-Sprenkels SD, Fielder M, Feltkamp TW, Tiwana H, Wilson C, Ebringer A. Antibodies to Klebsiella pneumoniae in Dutch patients with ankylosing spondylitis and acute anterior uveitis and to Proteus mirabilis in rheumatoid arthritis. J Rheumatol 1998;25:743-7.
9. Chou CT, Uksila J, Toivanen P. Enterobacterial antibodies in Chinese patients with rheumatoid arthritis and ankylosing spondylitis. Clin Exp Rheumatol 1998;16:161-4.
10. Wanchu A, Deodhar SD, Sharma M, Gupta V, Bambery P, Sud A. Elevated levels of anti-proteus antibodies in patients with active rheumatoid arthritis. Indian J Med Res 1997;105:39-42.
11. Subair H, Tiwana H, Fielder M et al. Elevation in anti-Proteus antibodies in patients with rheumatoid arthritis from Bermuda and England. J Rheumatol 1995;22:1825-8.
12. Tani Y, Tiwana H, Hukuda S et al. Antibodies to Klebsiella, Proteus, and HLA-B27 peptides in Japanese patients with ankylosing spondylitis and rheumatoid arthritis. J Rheumatol 1997; 24:109-14.
13. Khalafpour S, Ebringer A, Abuljadayel I, Corbett M. Antibodies to Klebsiella and Proteus microorganisms in ankylosing spondylitis and rheumatoid arthritis patients measured by ELISA. Br J Rheumatol 1988;27(Suppl. 2):86-9.
14. Maki-Ikola O, Penttinen M, Von Essen R, Gripenberg-Lerche C, Isomaki H, Granfors K. IgM, IgG and IgA class enterobacterial antibodies in serum and synovial fluid in patients with ankylosing spondylitis and rheumatoid arthritis. Br J Rheumatol 1997;36:1051-3.
15. Senior BW, Anderson GA, Morley KD, Kerr MA. Evidence that patients with rheumatoid arthritis have asymptomatic 'non-significant' Proteus mirabilis bacteriuria more frequently than healthy controls. J Infect 1999;38:99-106.
16. Wilson C, Senior BW, Tiwana H, Capparros-Wanderley W, Ebringer A. Antibiotic sensitivity and proticine typing of Proteus mirabilis strains associated with rheumatoid arthritis. Rheumatol Int 1998;17:203-5.
17. Wilson C, Thakore A, Isenberg D, Ebringer A. Correlation between anti-Proteus antibodies and isolation rates of P. mirabilis in rheumatoid arthritis. Rheumatol Int 1997;16:187-9.
18. Tiwana H, Wilson C, Alvarez A, Abuknesha R, Bansal S, Ebringer A. Cross-reactivity between the rheumatoid arthritis-associated motif EQKRAA and structurally related sequences found in Proteus mirabilis. Infect Immun 1999;67:2769-75.
19. Newkirk MM, Goldbach-Mansky R, Lee J et al. Advanced glycation end-product (AGE)-damaged IgG and IgM autoantibodies to IgG-AGE in patients with early synovitis. Arthritis Res Ther 2003; 5:R82-90.
20. Arnett FC, Edworthy SM, Bloch DA et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.
21. Dougados M, van der Linden S, Juhlin R et al. The European Spondylarthropathy Study Group preliminary criteria for the classification of spondylarthropathy. Arthritis Rheum 1991;34:1218-27.
22. Larsson P, Olling S. O antigen distribution and sensitivity to the bactericidal effect of normal human serum of Proteus strains from clinical specimens. Med Microbiol Immunol (Berl) 1977;163:77-82.
23. Ligier S, Fortin PR, Newkirk MM. A new antibody in rheumatoid arthritis targeting glycated IgG: IgM anti-IgG-AGE. Br J Rheumatol 1998;37:1307-14.
24. Lucey MD, Newkirk MM, Neville C, LePage K, Fortin PR. Association between IgM response to IgG damaged by glyoxidation and disease activity in rheumatoid arthritis. J Rheumatol 2000; 27:319-23.
25. El-Gabalawy HS, Goldbach-Mansky R, Smith D et al. Association of HLA alleles and clinical features in patients with synovitis of recent onset. Arthritis Rheum 1999;42:1696-705.
26. Neu HC. Urinary tract infections. Am J Med 1992;92:63S-70S.
27. Aoki S, Yoshikawa K, Yokoyama T et al. Role of enteric bacteria in the pathogenesis of rheumatoid arthritis: Evidence for antibodies to enterobacterial common antigens in rheumatoid sera and synovial fluids. Ann Rheum Dis 1996;55:363-9.
28. Maki-Ikola O, Hallgren R, Kanerud L, Feltelius N, Knutsson L, Granfors K. Enhanced jejunal production of antibodies to Klebsiella and other Enterobacteria in patients with ankylosing spondylitis and rheumatoid arthritis. Ann Rheum Dis 1997;56:421-5.
29. Deighton CM, Gray JW, Bint AJ, Walker DJ. Anti-Proteus antibodies in rheumatoid arthritis same-sexed sibships. Br J Rheumatol 1992;31:241-5.
30. Fielder M, Tiwana H, Youinou P et al. The specificity of the anti-Proteus antibody response in tissue-typed rheumatoid arthritis (RA) patients from Brest. Rheumatol Int 1995;15:79-82.
31. Tishler M, Caspi D, Almog Y, Segal R, Yaron M. Increased incidence of urinary tract infection in patients with rheumatoid arthritis and secondary Sjogren's syndrome. Ann Rheum Dis 1992;51:604-6.
32. Otto R, Kohler W. Inhibition of the rheumatoid factor (RF) in hemagglutination and Proteus agglutination tests by bacteria and their lipopolysaccharides. Z Immunitatsforsch Allerg Klin Immunol 1967;134:235-48.
33. Newkirk MM. Rheumatoid factors: Host resistance or autoimmunity? Clin Immunol 2002;104:1-13.
34. Leadbetter EA, Rifkin IR, Hohlbaum AM, Beaudette BC, Shlomchik MJ, Marshak-Rothstein A. Chromatin-IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors. Nature 2002;416:603-7.
35. Viglianti GA, Lau CM, Hanley TM, Miko BA, Shlomchik MJ, Marshak-Rothstein A. Activation of autoreactive B cells by CpG dsDNA. Immunity 2003;19:837-47.
36. Takeda K, Kaisho T, Akira S. Toll-like receptors. Annu Rev Immunol 2003;21:335-76
37. Korn A, Kroll HP, Berger HP et al. The 39-kilodalton outer membrane protein of Proteus mirabilis is an OmpA protein and mitogen for murine B lymphocytes. Infect Immun 1993;61:4915-8.
38. Izui S, Eisenberg RA, Dixon FJ. IgM rheumatoid factors in mice injected with bacterial lipopolysaccharides. J Immunol 1979; 122:2096-102.
39. Ebringer A, Wilson C, Tiwana H. Is rheumatoid arthritis a form of reactive arthritis? J Rheumatol 2000;27:559-63.
40. Wilson C, Ebringer A, Ahmadi K et al. Shared amino acid sequences between major histocompatibility complex class II glycoproteins, type XI collagen and Proteus mirabilis in rheumatoid arthritis. Ann Rheum Dis 1995;54:216-20.
41. Ebringer A, Wilson C. HLA molecules, bacteria and autoimmunity. J Med Microbiol 2000;49:305-11.